The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer Elizabeth A WellbergL Allyson CheckleySteven M Anderson Original Paper 24 July 2017 Pages: 269 - 285
Maternal Resveratrol Treatment Reduces the Risk of Mammary Carcinogenesis in Female Offspring Prenatally Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Tássia C. de Lima e SilvaLivia T. R. da SilveiraLuis F. Barbisan Original Paper 07 August 2017 Pages: 286 - 297
Expression of Genes for Methylxanthine Pathway-Associated Enzymes Accompanied by Sex Steroid Receptor Status Impacts Breast Carcinoma Progression James L. WittliffSeth B. SereffMichael W. Daniels Original Paper 02 October 2017 Pages: 298 - 313
Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer Helena PópuloBruno NunesPaula Soares Original Paper 18 September 2017 Pages: 314 - 324
Parity and Risk of Thyroid Cancer: a Population-Based Study in Lithuania L. ZabulieneD. JasilionisG. Smailyte Original Paper 15 September 2017 Pages: 325 - 329
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients Julien HadouxMarie TerroirEric Baudin Original Paper 26 July 2017 Pages: 330 - 337